Grant & Eisenhofer Represents Key Whistleblower in Justice Dept.'s $1.04 Billion Civil Settlement with GlaxoSmithKline

Grant & Eisenhofer Represents Key Whistleblower in Justice Dept.'s $1.04 Billion Civil Settlement with GlaxoSmithKline PR Newswire BOSTON and WASHINGTON, July 2, 2012 - G&E partner Reuben Guttman led team on behalf of a former GlaxoSmithKline Therapeutic Sales Manager who alleged misrepresentation in promotion of company's asthma/COPD drug Advair; firm's third major whistleblower recovery in 2012, following Abbott Labs' $1.6 billion settlement and banks' $25 billion payment over 'robo-signing' mortgage fraud BOSTON and WASHINGTON, July 2, 2012 /PRNewswire/ -- Leading whistleblower law firm Grant & Eisenhofer has represented one of several key whistleblowers behind a $1.04 billion settlement announced today between drug maker GlaxoSmithKline and the U.S. Department of Justice stemming from alleged marketing abuses of various GSK medications. Grant & Eisenhofer's client, Lois Graydon, is a nursing professional and former GSK Therapeutic Sales Manager. The U.S. Attorney's office in Boston led the investigation into promotional tactics behind a total of nine GSK drugs. An accompanying criminal component of the case is expected to substantially increase the sum of the recovery. Grant & Eisenhofer partner Reuben Guttman and senior counsel Traci Buschner are counsel to Lois Graydon, a registered nurse.